Supplemental Figure 1
-
Fig. S1. Mapping
of the mol‾/‾
mutation. Position of both the moltv53aand molst20 loci and foxa2 on a ZMAP panel of linkage group 17, showing both SSLP marker and gene
positions. moltv53a
embryos show 5/240 recombination events with z21703 and 8/68 with z21194.
Radiaton hybrid and meiotic mapping places foxa2 in the same interval (Woods et al., 2000)
(http://zfin.org/cgi-bin/webdriver?MIval=aa-markerview.apg&OID=ZDBGENE-980526-404).
moltv53a embryos show
0/88 recombination events with a marker placed within foxa2 itself. Sequence analysis of moltv53a embryos identified a point mutation of C to T in
nucleotide 496 of the open reading frame of foxa2, causing an amino acid change of glutamine 166 (CAA)
to stop (TAA). The tv53a mutation
is within the region encoding the forkhead domain of Foxa2 and causes a
truncation (Fig. 1E) that is likely to abolish activity of the protein.
Similarly, molst20 was
placed on LG17, in proximity to both z21703 and z9830 (one recombinant in 20
meioses for each). Sequence analysis of two exons of foxa2 from fin clips of heterozygous adult carriers
identified a point mutation of C to A, in nucleotide 534 of the open reading
frame. This leads to an amino acid substitution of tyrosine 178 (TAC) to stop
(TAA) (Fig. 1E). Similar to moltv53a,
this results in a truncation of Foxa2 within the DNA binding forkhead domain.
By scoring an Mse1 restriction
enzyme polymorphism introduced by the C to A mutation, this lesion
co-segregated with the molst20
mutation in 108 tested mutant embryos.